Home
Kevin Charles Gorman, Director: Xencor XNCR Sell · Filed 06/17
Trade details
- Type
- Insider sale
- Amount
- $92,657.37
- Shares · price
- 7,527 sh · $12.31 a share
- Held after
- 11,378 sh
- Stock
- Xencor XNCR
- Trade date
- 26/06/15
- Filed
- 26/06/17
- Days to filing
- 2 days
Sold 39.8% of holdings
- Share of holding sold
- 39.8%
Xencor trades, last 26 weeks
What else happened in Xencor around then
Filed or reported within 30 days of the trade day · 05/16~07/15Kevin Charles Gorman's recent trades
- Kevin Charles Gorman
Planned sale10b5-1 planXencor
Planned sale10b5-1 planXencor
XNCR
$92.7K
7,527 sh
$92.7K
Filed 06/15
Traded 06/15
- Kevin Charles Gorman
Sell10b5-1 planNeurocrine Biosciences
Sell10b5-1 planNeurocrine Biosciences
NBIX
$37.8M
245,088 sh
$37.8M
Filed 05/21
Traded 05/19
- Kevin Charles Gorman
Planned sale10b5-1 planNeurocrine Biosciences
Planned sale10b5-1 planNeurocrine Biosciences
NBIX
$38.5M
245,088 sh
$38.5M
Filed 05/19
Traded 05/19
- Kevin Charles Gorman
Sell10b5-1 planNeurocrine Biosciences
Sell10b5-1 planNeurocrine Biosciences
NBIX
$13.4M
106,322 sh
$13.4M
Filed 25/08/11
Traded 25/08/07
- Kevin Charles Gorman
Planned sale10b5-1 planNeurocrine Biosciences
Planned sale10b5-1 planNeurocrine Biosciences
NBIX
$13.7M
106,322 sh
$13.7M
Filed 25/08/07
Traded 25/08/07